ViCentra told customers that it expects no immediate impact from Dexcom's planned discontinuation of the G6 CGM line.
Adults with diabetes using an implantable 1-year continuous glucose monitoring sensor had a mean time in range of about 66% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results